HSBC lowered the firm’s price target on Epam Systems to $345 from $350 and keeps a Buy rating on the shares. Post Accenture’s guidance downgrade, concerns about the company’s 2024 growth have likely increased, the analyst tells investors in a research note. The firm sees demand picking up in the second half of 2024, but says the recovery could be slower.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EPAM:
- Epam Systems announces acquisition of Vates, terms not disclosed
- Epam Systems price target lowered to $236 from $250 at Morgan Stanley
- EPAM Systems Ties Executive Rewards to Performance Goals
- Epam Systems initiated with a Buy at Guggenheim
- Epam Systems price target raised to $315 from $305 at Barclays
